Colorado Center for Reproductive Medicine Statistics

2006 Statistics

Type of Cycle

Age of Woman    

Fresh Embryos from Nondonor Eggs

<35

35-37

38-40

41-42

>42

Number of cycles

275

195

166

76

33

Percentage of cycles resulting in pregnancies c 

71.3

59.5

53.0

35.5

33.3

Percentage of cycles resulting in live births b,c

62.2

49.7

41.0

26.3

18.2

Percentage of retrievals resulting in live births b,c

62.9

52.4

43.0

27.0

18.2

Percentage of transfers resulting in live births b,c

65.3

53.6

44.4

28.2

22.2

Percentage of cycles with elective single embryo transfer

5.0

1.7

0

1.4

0

Percentage of cancellations c

0.7

5.1

4.8

2.6

0

Implantation rate

48.9

31.2

25.2

12.8

9.4

Average number of embryos transferred

2.3

2.7

3.1

3.6

3.6

Percentages of live births with twins c

39.2

28.9

25.0

15.0

0/6

Percentage of live births with triplets or more c

2.9

2.1

2.9

0

0/6

 

 Frozen Embryos from Nondonor Eggs         

 

Age of Woman    

<35

35-37

38-40

41-42

Number of transfers

85

47

26

8

Percentage of Transfers resulting in live births b,c

48.2

53.2

42.3

4/8

Average number of embryos transferred

2.4

2.4

2.8

2.6

 

Donor Eggs

 

All Ages Combined e

Fresh Embryos

Frozen Embryos

Number of Transfers

201

79

Percentage of Transfers resulting in live births b,c

79.6

45.6

Average number of embryos transferred

2.1

2.3

a) Reflects patient and treatment characteristics of ART cycles performed in 2006 using fresh, nondonor eggs or embryos
b) Pregnancies resulting in one or more children born alive (i.e., a multiple-infant birth is counted as one live birth).
c) When fewer than 20 cycles using fresh, non-donor eggs or embryos are reported in any one category, live birth rates are shown as fractions, and reliability ranges are not given. Calculation of percentage based on a fraction may be misleading and is not encouraged.
d) All ages (including age >42) are reported together because previous data show that patient age does not materially affect success with donor eggs.
e) For patients older than 42 undergoing ART cycles using fresh, non-donor eggs or embryos, clinic-specific outcome rates are unreliable. Patients are urged to review national outcomes for these age groups.
 
The above information was submitted to SART (Society for Reproductive Technology) in January, 2008 for inclusion in its national report on 2006 IVF statistics. This information will be published by SART and will be posted on the CDC website in late 2008.  All information is current as of 3/31/2007.

Research cycles are included in SART data, not in CDC data, thus you will notice a difference in the SART and CDC data reports.